Physician profile

Alexander Duffy

Philadelphia, PA

NPI 1639732464

$2,565.13

in general payments reported to CMS, 2019-2025

5 companies · $116 in 2025

The $116 reported for 2025 was less than what a typical provider received nationally.

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Travel and Lodging$1,443.91
Food and Beverage$826.25

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Stryker Corporation $2,256.51 2022-2025 Scopis Ent, Xpress Loprofile, Actishield
Medtronic, INC. $250.12 2022
Dexcom, INC. $31.09 2025 Dexcom G6 Transmitter
Boehringer Ingelheim Pharmaceuticals, INC. $14.97 2025 Jardiance
Allergan, INC. $12.44 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Alexander Duffy

$2,565.13

in general payments reported 2019-2025

Years
2020-2025
Top company
Stryker Corporation
Context
The $116 reported for 2025 was less than what a typical provider received nationally.

https://glasscript.com/doctor/7233428/alexander-duffy

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.